Inflammatix Bacterial Viral Noninfected Version 3 Bacterial Interpretation Bands Compared to Clinically Adjudicated Bacterial Infection Status
| IMX-BVN-3 Bacterial Band . | Bacterial Infection Status by Clinical Adjudication, No. (%)a . | % in Band . | Sensitivity, % . | Specificity, % . | Likelihood Ratio . | |
|---|---|---|---|---|---|---|
| Not Infected (n = 86) . | Infected (n = 18) . | |||||
| Very likely | 0 (0.0) | 3 (16.7) | 2.9 | NR | 100 | Infinite |
| Possible | 1 (1.2) | 3 (16.7) | 3.8 | NR | 98.9 | 14.3 |
| Unlikely | 38 (44.2) | 6 (33.3) | 42.3 | 66.7 | NR | 0.75 |
| Very unlikely | 47 (54.7) | 6 (33.3) | 51 | 66.7 | NR | 0.61 |
| IMX-BVN-3 Bacterial Band . | Bacterial Infection Status by Clinical Adjudication, No. (%)a . | % in Band . | Sensitivity, % . | Specificity, % . | Likelihood Ratio . | |
|---|---|---|---|---|---|---|
| Not Infected (n = 86) . | Infected (n = 18) . | |||||
| Very likely | 0 (0.0) | 3 (16.7) | 2.9 | NR | 100 | Infinite |
| Possible | 1 (1.2) | 3 (16.7) | 3.8 | NR | 98.9 | 14.3 |
| Unlikely | 38 (44.2) | 6 (33.3) | 42.3 | 66.7 | NR | 0.75 |
| Very unlikely | 47 (54.7) | 6 (33.3) | 51 | 66.7 | NR | 0.61 |
Abbreviations: IMX-BVN-3, Inflammatix Bacterial Viral Noninfected version 3; NR, not reported.
Clinical adjudication was performed in 104 of 111 patients (7 patients lost to follow-up).
Inflammatix Bacterial Viral Noninfected Version 3 Bacterial Interpretation Bands Compared to Clinically Adjudicated Bacterial Infection Status
| IMX-BVN-3 Bacterial Band . | Bacterial Infection Status by Clinical Adjudication, No. (%)a . | % in Band . | Sensitivity, % . | Specificity, % . | Likelihood Ratio . | |
|---|---|---|---|---|---|---|
| Not Infected (n = 86) . | Infected (n = 18) . | |||||
| Very likely | 0 (0.0) | 3 (16.7) | 2.9 | NR | 100 | Infinite |
| Possible | 1 (1.2) | 3 (16.7) | 3.8 | NR | 98.9 | 14.3 |
| Unlikely | 38 (44.2) | 6 (33.3) | 42.3 | 66.7 | NR | 0.75 |
| Very unlikely | 47 (54.7) | 6 (33.3) | 51 | 66.7 | NR | 0.61 |
| IMX-BVN-3 Bacterial Band . | Bacterial Infection Status by Clinical Adjudication, No. (%)a . | % in Band . | Sensitivity, % . | Specificity, % . | Likelihood Ratio . | |
|---|---|---|---|---|---|---|
| Not Infected (n = 86) . | Infected (n = 18) . | |||||
| Very likely | 0 (0.0) | 3 (16.7) | 2.9 | NR | 100 | Infinite |
| Possible | 1 (1.2) | 3 (16.7) | 3.8 | NR | 98.9 | 14.3 |
| Unlikely | 38 (44.2) | 6 (33.3) | 42.3 | 66.7 | NR | 0.75 |
| Very unlikely | 47 (54.7) | 6 (33.3) | 51 | 66.7 | NR | 0.61 |
Abbreviations: IMX-BVN-3, Inflammatix Bacterial Viral Noninfected version 3; NR, not reported.
Clinical adjudication was performed in 104 of 111 patients (7 patients lost to follow-up).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
